PRGO - רווח נקי למניה (EPS TTM) Perrigo Company PLC

Perrigo Company plc (PRGO) management is currently restructuring internal processes to drive profitability growth, supported by developments in drug bioavailability and eco-packaging. Business revenues are based on mass supplies of over-the-counter medicines to global retail chains. The rolling annual earnings per share visualizes the financial condition, while -12.71 shows the current value of this metric.

Net income per share (TTM) consolidates the annual financial result by dividing total income by the number of securities to assess the business's actual profitability. Analyzing this chart of net income per share over the last 12 months, an investor can see the sensitivity of Perrigo Company plc (PRGO) margins to infant nutrition restructuring costs and production recall risks, which could offset the stability of the core drug portfolio.